Examiner: REDDIG, PETER J

Tech Center 1600 • Art Units: 1633 1642 1644 1646

This examiner grants 58% of resolved cases

Performance Statistics

58.1%

Allow Rate

-1.9% vs TC avg

1,075

Total Applications

+39.9%

Interview Lift

1253

Avg Prosecution Days

Based on 1030 resolved cases, 2023–2026

7.3%

§101 Eligibility

18.9%

§102 Novelty

24.8%

§103 Obviousness

29.9%

§112 Clarity

App #	Title	Status	Assignee
18016209	METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION	Non-Final OA	Dana-Farber Cancer Institute, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.